Skip to the page

Data / Form D filings / CYTOMETIX INC

CYTOMETIX INC: Form D filing

CYTOMETIX INC, a pharmaceuticals company in Milwaukee, WI, filed a Form D with the SEC in 2010. The latest, on July 16, 2010, reports $1.9 million sold of a $2 million offering to 23 investors.

Find out what CYTOMETIX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
756 North Milwaukee Street, Suite 250, Milwaukee, WI, 53202
Phone
(414) 727-1726
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Wisconsin
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1427524

The full lists. Form D filings in Wisconsin: 361 rows, $18.05, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 16, 2010New notice$2,000,000$1,910,000$90,00023Jul 2, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Frank CastellanaDirector
David HarderExecutive Officer, Director
John LuellwitzExecutive Officer, Director
Lane BrostromExecutive Officer, Director
Eckhart GrohmannDirector

Every Form D from the week of Jul 12, 2010 · All recent filings in Wisconsin · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what CYTOMETIX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.